Log In
BCIQ
Print this Print this
 

NEO-201 (formerly 16C3)

  Manage Alerts
Collapse Summary General Information
Company Precision Biologics Inc.
DescriptionHuman mAb targeting a variant of carcinoembryonic antigen (CEA)-related cell adhesion molecule 5 (CEACAM5; CD66e) and CEACAM6
Molecular Target Carcinoembryonic antigen (CEA)-related cell adhesion molecule 5 (CEACAM5) (CD66e) ; Carcinoembryonic antigen (CEA)-related cell adhesion molecule 6 (CEACAM6) (NCA) (CD66c)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentIND
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today